Lama Alfehaid, Ahmed Alanazi, Nada Alsuhebany, Khaled Alamer, Hadi Naji Skouri. "Multi-center real-world validation of the HFA-ICOS cardio-oncology risk tool in HER2-positive breast cancer patients receiving anti-HER2 therapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e24015